Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma.

CONCLUSION: The inclusion of NTZ to CCRT is more effective for long-term survival among LA-NPC patients than CCRT only.
PMID: 30081714 [PubMed - as supplied by publisher]

Source: Cancer Biology and Therapy - August 6, 2018 Category: Cancer & Oncology Authors: Yao JJ, Zhang LL, Gao TS, Peng YL, Lawrence WR, Zhang WJ, Zhang F, Zhou GQ, Wang SY, Sun Y Tags: Cancer Biol Ther Source Type: research